FLAGYL ER Drug Patent Profile
✉ Email this page to a colleague
When do Flagyl Er patents expire, and what generic alternatives are available?
Flagyl Er is a drug marketed by Pfizer and is included in one NDA.
The generic ingredient in FLAGYL ER is metronidazole. There are eighteen drug master file entries for this compound. Sixty-nine suppliers are listed for this compound. Additional details are available on the metronidazole profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Flagyl Er
A generic version of FLAGYL ER was approved as metronidazole by TEVA PHARMS USA on November 6th, 1984.
Summary for FLAGYL ER
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 172 |
Clinical Trials: | 74 |
Patent Applications: | 2,255 |
Formulation / Manufacturing: | see details |
DailyMed Link: | FLAGYL ER at DailyMed |
Recent Clinical Trials for FLAGYL ER
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Leiden University Medical Center | Phase 4 |
University of Amsterdam | Phase 2 |
University of North Carolina, Chapel Hill | Phase 2 |
Anatomical Therapeutic Chemical (ATC) Classes for FLAGYL ER
US Patents and Regulatory Information for FLAGYL ER
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Pfizer | FLAGYL ER | metronidazole | TABLET, EXTENDED RELEASE;ORAL | 020868-001 | Nov 26, 1997 | DISCN | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for FLAGYL ER
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Pfizer | FLAGYL ER | metronidazole | TABLET, EXTENDED RELEASE;ORAL | 020868-001 | Nov 26, 1997 | ⤷ Try a Trial | ⤷ Try a Trial |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
International Patents for FLAGYL ER
See the table below for patents covering FLAGYL ER around the world.
Country | Patent Number | Title | Estimated Expiration |
---|---|---|---|
New Zealand | 279368 | MODIFIED-RELEASE METRONIDAZOLE (A NITROIMIDAZOLE) COMPOSITIONS | ⤷ Try a Trial |
Canada | 2181985 | COMPOSITIONS DE METRONIDAZOLE A LIBERATION MODIFIEE ET LEURS PROCEDES DE FABRICATION ET D'UTILISATION (MODIFIED-RELEASE METRONIDAZOLE COMPOSITIONS AND METHODS FOR MAKING AND USING SAME) | ⤷ Try a Trial |
Brazil | 9506662 | ⤷ Try a Trial | |
Spain | 2174930 | ⤷ Try a Trial | |
European Patent Office | 0744947 | COMPOSITIONS DE METRONIDAZOLE A LIBERATION MODIFIEE ET LEURS PROCEDES DE FABRICATION ET D'UTILISATION (MODIFIED-RELEASE METRONIDAZOLE COMPOSITIONS AND METHODS FOR MAKING AND USING SAME) | ⤷ Try a Trial |
>Country | >Patent Number | >Title | >Estimated Expiration |
Supplementary Protection Certificates for FLAGYL ER
Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
---|---|---|---|---|
0328535 | 96C0021 | Belgium | ⤷ Try a Trial | PRODUCT NAME: LANSOPRAZOLE + CLARITHROMYCINE + METRONIDAZOLE; REGISTRATION NO/DATE IN FRANCE: K 27 17033R DU 19960209; REGISTRATION NO/DATE AT EEC: K 27 17033R DU 19960209 |
>Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |